Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as much weight as an Eli Lilly product.
Home Depot’s stock set to surge as sales growth provides signs of a turnaround
Home Depot’s stock was set to surge after quarterly comparable sales snapped a streak of misses, and profit beat by the widest margin in years.
